Greencape Capital Pty LTD Abbott Laboratories Transaction History

Greencape Capital Pty LTD

$241 Million
Q2 2024

A detailed history of Greencape Capital Pty LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Greencape Capital Pty LTD holds 701,387 shares of ABT stock, worth $80.1 Million. This represents 30.26% of its overall portfolio holdings.

Number of Shares

701,387

Previous 609,587 15.06%

Holding current value

$80.1 Million

Previous $69.3 Million 5.19%

% of portfolio

30.26%

Previous 27.78%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $9.25 Million - $10.3 Million	91,800 Added 15.06%	701,387 $72.9 Million
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $2.38 Million - $2.62 Million	-21,700 Reduced 3.44%	609,587 $69.3 Million
Q4 2023 Jan 25, 2024	BUY	$90.19 - $110.4 $1.32 Million - $1.62 Million	14,687 Added 2.38%	631,287 $69.5 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $35.1 Million - $42.2 Million	367,800 Added 147.83%	616,600 $59.7 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $25.1 Million - $27.9 Million	248,800 New	248,800 $27.1 Million
Q3 2020 Feb 10, 2021	SELL	$91.64 - $111.29 $8.57 Million - $10.4 Million	-93,564 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $12.6 Million - $16.1 Million	-164,700 Reduced 63.77%	93,564 $8.56 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $4.49 Million - $6.57 Million	-71,500 Reduced 21.68%	258,264 $20.4 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $21.2 Million - $23.6 Million	-269,936 Reduced 45.01%	329,764 $28.6 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $3.17 Million - $3.43 Million	38,700 Added 6.9%	599,700 $50.2 Million
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $40.9 Million - $47.7 Million	561,000 New	561,000 $47.2 Million

Others Institutions Holding ABT

# of Institutions

3,134

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greencape Capital Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Greencape Capital Pty LTD with notifications on news.

Account

Greencape Capital Pty LTD Abbott Laboratories Transaction History